Shroufi A, van Cutsem G, Cambiano V, Bansi-Matharu L, Duncan K, et al.
2019-08-01 • AIDS
2019-08-01 • AIDS
BACKGROUND Many individuals failing first-line antiretroviral therapy (ART) in sub-Saharan Africa never initiate second-line ART or do so after significant delay. For people on ART w...
Phillips AN, Cambiano V, Johnson LF, Nakagawa F, Homan R, et al.
2019-12-18 • Journal of Infectious Diseases
2019-12-18 • Journal of Infectious Diseases
Abstract
INTRODUCTION:
Oral pre-exposure prophylaxis (PrEP) in the form of tenofovir-disoproxil-fumarate/emtricitabine is being implemented in selected sites in South Africa. A...
Phillips AN, Shroufi A, Vojnov L, Cohn J, Roberts TR, et al.
2015-12-01 • Nature
2015-12-01 • Nature
There are inefficiencies in current approaches to monitoring patients on antiretroviral therapy in sub-Saharan Africa. Patients typically attend clinics every 1 to 3 months for clinical ...
